Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel mutation in KIF23 causing congenital dyserythropoietic anemia type III in patients who underwent allogeneic hematopoietic stem cell transplantation.
Fujikawa T, Uemura S, Hasegawa D, Morisada N, Nakamura S, Kozaki A, Saito A, Kishimoto K, Ishida T, Mori T, Yakushijin K, Katayama Y, Yamashita D, Wakamatsu M, Hamada M, Muramatsu H, Takahashi Y, Kosaka Y. Fujikawa T, et al. Among authors: yakushijin k. Pediatr Blood Cancer. 2024 Jun;71(6):e30736. doi: 10.1002/pbc.30736. Epub 2024 Mar 24. Pediatr Blood Cancer. 2024. PMID: 38523246 No abstract available.
Pharmacokinetics-based optimal dose-exploration of mycophenolate mofetil in allogeneic hematopoietic stem cell transplantation.
Okamura A, Yamamori M, Shimoyama M, Kawano Y, Kawano H, Kawamori Y, Nishikawa S, Minagawa K, Yakushijin K, Katayama Y, Sakaeda T, Hirai M, Matsui T. Okamura A, et al. Among authors: yakushijin k. Int J Hematol. 2008 Jul;88(1):104-110. doi: 10.1007/s12185-008-0093-4. Epub 2008 May 14. Int J Hematol. 2008. PMID: 18473127 Clinical Trial.
Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.
Yakushijin K, Atsuta Y, Doki N, Yokota A, Kanamori H, Miyamoto T, Ohwada C, Miyamura K, Nawa Y, Kurokawa M, Mizuno I, Mori T, Onizuka M, Taguchi J, Ichinohe T, Yabe H, Morishima Y, Kato K, Suzuki R, Fukuda T. Yakushijin K, et al. Bone Marrow Transplant. 2016 Mar;51(3):403-9. doi: 10.1038/bmt.2015.283. Epub 2015 Nov 23. Bone Marrow Transplant. 2016. PMID: 26595082 Clinical Trial.
Use of mycophenolate mofetil and a calcineurin inhibitor in allogeneic hematopoietic stem-cell transplantation from HLA-matched siblings or unrelated volunteer donors: Japanese multicenter phase II trials.
Nakane T, Nakamae H, Yamaguchi T, Kurosawa S, Okamura A, Hidaka M, Fuji S, Kohno A, Saito T, Aoyama Y, Hatanaka K, Katayama Y, Yakushijin K, Matsui T, Yamamori M, Takami A, Hino M, Fukuda T. Nakane T, et al. Among authors: yakushijin k. Int J Hematol. 2017 Apr;105(4):485-496. doi: 10.1007/s12185-016-2154-4. Epub 2016 Dec 9. Int J Hematol. 2017. PMID: 27943166 Clinical Trial.
Human CD134 (OX40) expressed on T cells plays a key role for human herpesvirus 6B replication after allogeneic hematopoietic stem cell transplantation.
Nagamata S, Nagasaka M, Kawabata A, Kishimoto K, Hasegawa D, Kosaka Y, Mori T, Morioka I, Nishimura N, Iijima K, Yamada H, Kawamoto S, Yakushijin K, Matsuoka H, Mori Y. Nagamata S, et al. Among authors: yakushijin k. J Clin Virol. 2018 May;102:50-55. doi: 10.1016/j.jcv.2018.02.011. Epub 2018 Feb 21. J Clin Virol. 2018. PMID: 29494951
184 results